De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator On-Demand Webinar De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator Watch the on-demand presentation covering how the DIDB® Concomitant Meds Navigator empowers clinical development teams…CertaraAugust 5, 2025
Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials Blog Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…CertaraJuly 31, 2025
MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines On-Demand Webinar MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.CertaraJuly 29, 2025
Three Approaches to AI Adoption in Regulatory Writing On-Demand Webinar Three Approaches to AI Adoption in Regulatory Writing Certara experts discuss AI adoption in medical writing: learn practical models, GenAI & SCA integration,…CertaraJuly 23, 2025
How to Create a Data Validation Plan in Clinical Data Management Guide How to Create a Data Validation Plan in Clinical Data Management Download our guide to creating a data validation plan in clinical data management, the ultimate…CertaraJuly 21, 2025
Needle in the Haystack: The Role of Data Fabrics in Successful AI Implementation On-Demand Webinar Needle in the Haystack: The Role of Data Fabrics in Successful AI Implementation CertaraJuly 18, 2025
Pirana Tips and Tricks – Report Object Generation in Pirana Webinar Pirana Tips and Tricks – Report Object Generation in Pirana CertaraJuly 1, 2025
The Reference-scaled Average Bioequivalence (RSABE) Approach Blog The Reference-scaled Average Bioequivalence (RSABE) Approach We examine the Reference-scaled Average Bioequivalence (RSABE) approach for generic drug development and how it…CertaraJuly 1, 2025
5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address Blog 5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…CertaraJune 30, 2025
Maintain & Adapt Pharma Market Access Digital Tools Using Feedback Blog Maintain & Adapt Pharma Market Access Digital Tools Using Feedback Maintain the credibility of your pharma market access digital tools through continuous updates based on…CertaraJune 30, 2025